REFERENCES

• KrausL.AugustinR.OrthBIllégale Drogen, Einstiegsalter und Trends. Ergebnisse des Epidemiologischen Suchtsurvey 2003.Sucht.200551,S11928
   Google Scholar
• TossmannP.BoldtS.TensilMD.The use of drugs within the techno party scene in European metropolitan cities.Eur Addict Res.2001722311316921
   PubMed Web of Science ®Google Scholar
• StroteJ.LeeJE.WechslerH.Increasing MDMA use among college students: results of a national survey.J Adolesc Health.200230647211755802
   PubMed Web of Science ®Google Scholar
• GreenAR.MechanAO.ElliottJM.et al.The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”).Pharmacol Rev.20035546350812869661
   PubMed Web of Science ®Google Scholar
• YacoubianGS.JrBoyleC.HardingCA.et al.It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees.J Drug Educ.20033318719612929709
   PubMed Web of Science ®Google Scholar
• QuintonMS.YamamotoBK.Causes and consequences of methamphetamine and MDMA toxicity.AAPS J.20068E337E34716796384
   PubMed Web of Science ®Google Scholar
• GouzoulisE.BorchardtD.Hermle LA case of toxic psychosis induced by 'eve' (3,4-methylenedioxyethylamphetamine).Arch Gen Psychiatry.199350758093659
   PubMed Web of Science ®Google Scholar
• ParrottAC.Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.J Psychopharmacol.200519718315671132
   PubMed Web of Science ®Google Scholar
• RicaurteGA.MartelloAL.KatzJL.et al.Lasting effects of (+-)-3,4methylenedioxymeth-iamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.J Pharmacol Exp Ther.19922616166221374470
   PubMed Web of Science ®Google Scholar
• FischerC.HatzidimitriouG.WlosJ.et al.Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”).J Neurosci.19951 5547654857643196
   PubMedGoogle Scholar
• HatzidimitriouG.McCannUD.RicaurteGA.Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery.J Neurosci.1999195096510710366642
   PubMed Web of Science ®Google Scholar
• RicaurteGA.McCannUD.SzaboZ.et al.Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').Toxicol Lett.2000112-11314314610720723
   PubMed Web of Science ®Google Scholar
• SeidenLS.SabolKE.Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction.MDA Res Monogr.1996163251276
   PubMedGoogle Scholar
• McCannUD.RicaurteGA.Amphetamine neurotoxicity: accomplishments and remaining challenges.Neurosci Biobehav Rev.20042782182615019431
   PubMed Web of Science ®Google Scholar
• HansonGR.RauKS.FleckensteinAE.The methamphetamine experience: a NIDA partnership.Neuropharmacology.200447 (suppl 1)9210015464128
   PubMed Web of Science ®Google Scholar
• MelegaWP.JorgensenMJ.LacanG.et al.Long-term methamphetamine administration in thevervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.Neuropsychopharmacology.2008331441145217625500
   PubMed Web of Science ®Google Scholar
• WoolvertonWL.RicaurteGA.FornoLS.et al.Long-term effects of chronic methamphetamine administration in rhesus monkeys.Brain Res.198948673782720435
   PubMed Web of Science ®Google Scholar
• SlikkerW.Jr.HolsonRR.AliSF.et al.Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.Neurotoxicology.1989 105295422576304
   PubMed Web of Science ®Google Scholar
• FrederickDL.PauleMG.Effects of MDMA on complex brain function in laboratory animals.Neurosci Biobehav Rev.19972167788994210
   PubMed Web of Science ®Google Scholar
• TaffeMA.DavisSA.YuanJ.et al.Cognitive performance of MDMAtreated rhesus monkeys: sensitivity to serotonergic challenge.Neuropsychopharmacology.200227993100512464456
   PubMed Web of Science ®Google Scholar
• LuckiI.The spectrum of behaviors influenced by serotonin.Biol Psychiatry.1998441511629693387
   PubMed Web of Science ®Google Scholar
• WeigerWA.Serotonergic modulation of behaviour: a phylogenetic overview.Biol Rev Camb Philos Soc.19977261959116165
   PubMed Web of Science ®Google Scholar
• MarstonHM.ReidME.LawrenceJA.et al.Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat.Psychopharmacology.1999144677610379626
   PubMed Web of Science ®Google Scholar
• MorleyKC.GallateJE.HuntGE.et al.Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (“ecstasy”).Eur J Pharmacol.2001433919911755138
   PubMed Web of Science ®Google Scholar
• BroeningHW.MorfordLL.Inman-WoodSL.et al.3,4-methylenedioxymethamphetamine (ecstasy )-induced learning and memory impairments depend on the age of exposure during early development.J Neurosci.2001213228323511312307
   PubMed Web of Science ®Google Scholar
• TaffeMA.Huitron-ResendizS.SchroederR.et al.MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys.Pharmacol Biochem Behav.20037614115213679227
   PubMed Web of Science ®Google Scholar
• McGregorIS.GurtmanCG.MorleyKC.et al.Increased anxiety and “depressive” symptoms months after MDMA (“ecstasy”) in rats: druginduced hyperthermia does not predict long-term outcomes.Psychopharmacology.200316846547412700882
   PubMed Web of Science ®Google Scholar
• McGregorIS.ClemensKJ.Van der PGet al.Increased anxiety 3 months after brief exposure to MDMA (“Ecstasy”) in rats: association with altered 5-HT transporter and receptor density.Neuropsychopharmacology.2003281472148412700695
   PubMed Web of Science ®Google Scholar
• SpragueJE.PrestonAS.LeifheitM.et al.Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning.Physiol Behav.20037928128712834800
   PubMed Web of Science ®Google Scholar
• FariaR.MagalhaesA.MonteiroPR.et al.MDMA in adolescent male rats: decreased serotonin in the amygdala and behavioral effects in the elevated plus-maze test.Ann N Y Acad Sci.2006107464364917105959
   PubMed Web of Science ®Google Scholar
• TaffeMA.WeedMR.DavisS.et al.Functional consequences of repeated (+/-)3,4-methylene->dioxymethamphetamine (MDMA) treatment in rhesus monkeys.Neuropsychopharmacology.20012423023911166514
   PubMed Web of Science ®Google Scholar
• WinsauerPJ.McCannUD.YuanJ.et al.Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration.Psychopharmacology.200215938839611823891
   PubMed Web of Science ®Google Scholar
• TimarJ.GyarmatiS.SzaboA.et al.Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives.Behav Pharmacol.20031419920612799521
   PubMed Web of Science ®Google Scholar
• MechanAO.MoranPM.ElliottM.et al.A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”) on the subsequent long-term behaviour of rats in the plus maze and open field.Psychopharmacology.200215916717511862345
   PubMed Web of Science ®Google Scholar
• GurtmanCG.MorleyKC.LiKM.et al.Increased anxiety in rats after 3,4methylenedioxy-imethamphetamine: association with serotonin depletion.Eur J Pharmacol.2002446899612098589
   PubMed Web of Science ®Google Scholar
• WalshSL.WagnerGC.Motor impairments after methamphetamineinduced neurotoxicity in the rat.J Pharmacol Exp Ther.19922636176261432692
   PubMed Web of Science ®Google Scholar
• Chat-MendesC.AndersonKL.ItzhakY.Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.Neuropsychopharmacology.20073253154116760923
   PubMed Web of Science ®Google Scholar
• ChapmanDE.HansonGR.KesnerRP.et al.Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.J Pharmacol Exp Ther.200129652052711160639
   PubMed Web of Science ®Google Scholar
• BelcherAM.O'DellSJ.MarshallJF.Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity.Neuropsychopharmacology.2005302026203415900317
   PubMed Web of Science ®Google Scholar
• HeJ.YangY.YuY.et al.The effects of chronic administration of quetiapine on the methamphe-itamine-induced recognition memory impairment and dopaminergic terminal deficit in rats.Behav Brain Res.2006172394516712969
   PubMed Web of Science ®Google Scholar
• BelcherAM.FeinsteinEM.O'DellSJ.et al.Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens.Neuropsychopharmacology.2008331453146317637607
   PubMed Web of Science ®Google Scholar
• De LaGR.FabrizioKR.GuptaA.Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns.Psychopharmacology.200718942543416470404
   PubMed Web of Science ®Google Scholar
• BermanSM.KuczenskiR.McCrackenJT.et al.Potential adverse effects of amphetamine treatment on brain and behavior: a review.Mol Psychiatry.20091412314218698321
   PubMed Web of Science ®Google Scholar
• Gouzoulis-MayfrankE.DaumannJ.Neurotoxicity of méthylènedioxyamphétamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?.Addiction.200610134836116499508
   PubMed Web of Science ®Google Scholar
• FantegrossiWE.WoolvertonWL.KilbournM.et al.Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.Neuropsychopharmacology.2004291270128115039771
   PubMed Web of Science ®Google Scholar
• ColadoMl.GranadosR.O'SheaE.et al.Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker ARR15896AR.Br J Pharmacol.19981244794849647471
   PubMed Web of Science ®Google Scholar
• CohenZ.BonventoG.LacombeP.et al.Serotonin in the regulation of brain microcirculation.Prog Neurobiol.1996503353629004349
   PubMed Web of Science ®Google Scholar
• AzmitiaEC.Serotonin neurons, neuroplasticity, and homeostasis of neural tissue.Neuropsychopharmacology.19992133S45S10432487
   PubMed Web of Science ®Google Scholar
• GouldE.Serotonin and hippocampal neurogenesis.Neuropsychopharmacology.19992146S51S10432488
   PubMed Web of Science ®Google Scholar
• ChangL.GrobCS.ErnstT.et al.Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study.Psychiatry Res.200098152810708923
   PubMed Web of Science ®Google Scholar
• GammaA.BuckA.BertholdT.et al.No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)0]-positron emission tomography study.J Clin Psychopharmacol.200121667111199950
   PubMed Web of Science ®Google Scholar
• RenemanL.MajoieCB.HabrakenJB.et al.Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging.Radiology.200122061161711526257
   PubMed Web of Science ®Google Scholar
• GammaA.BuckA.BertholdVollenweiderFX.No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetatnine) users and control subjects: a [H2(15)0]-positron emission tomography study.J Clin Psychopharmacol.200121(1)667111199950
   PubMed Web of Science ®Google Scholar
• CowanRL.LyooIK.SungSM.et al.Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.Drug Alcohol Depend.20037222523514643939
   PubMed Web of Science ®Google Scholar
• ChangL.ErnstT.GrobCS.et al.Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users.J Magn Reson Imaging.19991052152610508318
   PubMed Web of Science ®Google Scholar
• RenemanL.MajoieCB.FlickH.et al.Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.Am J Neuroradiol.20022323123711847047
   PubMed Web of Science ®Google Scholar
• DaumannJ.FischermannT.PilatusU.et al.Proton magnetic resonance spectroscopy in ecstasy (MDMA) users.Neurosci Lett.200436211311615193766
   PubMed Web of Science ®Google Scholar
• de WinMM.JagerG.BooijJ.et al.Neurotoxic effects of ecstasy on the thalamus.Br J Psychiatry.200819328929618827290
   PubMed Web of Science ®Google Scholar
• de WinMM.JagerG.BooijJ.et al.Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.Brain.20081312936294518842607
   PubMed Web of Science ®Google Scholar
• PeroutkaSJ.PascoeN.FaullKF.Monoamine metabolites in the cerebrospinal fluid of recreational users of 3,4-methylenedimethoxymethamphetamine (MDMA; “ecstasy”).Res Comm Subst Abuse.1987812537
   Google Scholar
• RicaurteGA.FinneganKT.IrwinI.et al.Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.Ann N Y Acad Sci.19906006997081701292
   PubMed Web of Science ®Google Scholar
• BollaKl.McCannUD.RicaurteGA.Memory impairment in abstinent MDM A (“ Ecstasy”) users.Neurology.199851153215379855498
   PubMed Web of Science ®Google Scholar
• McCannUD.RidenourA.ShahamY.et al.Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; “Ecstasy”): a controlled study in humans.Neuropsychopharmacology.1994101291387517677
   PubMed Web of Science ®Google Scholar
• McCannUD.MertlM.EligulashviliV.et al.Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study.Psychopharmacology.199914341742510367560
   PubMed Web of Science ®Google Scholar
• McCannUD.SzaboZ.ScheffelU.et al.Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings. .Lancet.1998352143314379807990
   PubMed Web of Science ®Google Scholar
• SempleDM.EbmeierKP.GlabusMF.et al.Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users.Br J Psychiatry.1999175636910621770
   PubMed Web of Science ®Google Scholar
• McCannUD.SzaboZ.SeckinE.et al.Quantitative PET studies of the serotonin transporter in MDMA users and controls using [(1 1)C]McN5652 and [(11)C]DASB.Neuropsychopharmacology.2005301741175015841106
   PubMed Web of Science ®Google Scholar
• ThomasiusR.PetersenK.BuchertR.et al.Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.Psychopharmacology.2003167859612632248
   PubMed Web of Science ®Google Scholar
• RenemanL.BooijJ.de BruinK.et al.Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.Lancet.20013581864186911741626
   PubMed Web of Science ®Google Scholar
• RenemanL.LavalayeJ.SchmandB.et al.Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”): preliminary findings.Arch Gen Psychiatry.20015890190611576026
   PubMed Web of Science ®Google Scholar
• BuchertR.ThomasiusR.NebelingB.et al.Long-term effects of “Ecstasy” use on serotonin transporters of the brain investigated by PET.J NuclMed.200344375384
   Google Scholar
• BuchertR.ThomasiusR.WilkeF.et al.A voxel-based PET investigation of the long-term effects of “Ecstasy” consumption on brain serotonin transporters.Am J Psychiatry.20041611181118915229049
   PubMed Web of Science ®Google Scholar
• SelvarajS.HoshiR.BhagwagarZ.et al.Brain serotonin transporter binding in former users of MDMA ('ecstasy').Br J Psychiatry.200919435535919336788
   PubMed Web of Science ®Google Scholar
• BuchertR.ThomasiusR.PetersenK.et al.Reversibility of ecstasyinduced reduction in serotonin transporter availability in polydrug ecstasy users.Eur J Nucl Med Mol Imaging.20063318819916133393
   PubMed Web of Science ®Google Scholar
• RenemanL.EndertE.de BruinK.et al.The acute and chronic effects of MDMA (“ecstasy”) on cortical 5-HT2A receptors in rat and human brain.Neuropsychopharmacology.20022638739611850153
   PubMed Web of Science ®Google Scholar
• ScheffelU.LeverJR.StathisM.et al.Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors.Neuropharmacology.1992318818931359444
   PubMed Web of Science ®Google Scholar
• HegadorenKM.BakerGB.BourinM.3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.Neurosci Biobehav Rev19992353955310073892
   PubMed Web of Science ®Google Scholar
• SchifanoF.Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies.Neuropsychobiology.200042253310867553
   PubMed Web of Science ®Google Scholar
• SchifanoF.Di FuriaL.ForzaG.et al.MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.Drug Alcohol Depend.19985285909788011
   PubMed Web of Science ®Google Scholar
• ToppL.HandoJ.DillonP.et al.Ecstasy use in Australia: patterns of use and associated harm.Drug Alcohol Depend.19995510511510402155
   PubMed Web of Science ®Google Scholar
• LiebR.SchuetzC.PfisterH.et al.Mental disorders in ecstasy users: a prospective-longitudinal investigation.Drug Alcohol Depend.20026819512234649
   PubMed Web of Science ®Google Scholar
• DaumannJ.PelzS.BeckerS.et al.Psychological profile of abstinent recreational ecstacy (MDMA) users and significance of concomitant cannabis use.Human Psychopharmacology.20011662763312404543
   PubMed Web of Science ®Google Scholar
• MorganMJ.McFieL.FleetwoodH.et al.Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?.Psychopharmacology.200215929430311862362
   PubMed Web of Science ®Google Scholar
• DaumannJ.HensenG.ThimmB.et al.Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.Psychopharmacology.200417339840414722704
   PubMed Web of Science ®Google Scholar
• ParrottAC.MilaniRM.ParmarR.et al.Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.Psychopharmacology.2001159778211797073
   PubMed Web of Science ®Google Scholar
• RoiserJP.SahakianBJ.Relationship between ecstasy use and depression: a study controlling for poly-drug use.Psychopharmacology.200417341141714652710
   PubMed Web of Science ®Google Scholar
• de WinMM.RenemanL.ReitsmaJB.et al.Mood disorders and serotonin transporter density in ecstasy users-the influence of long-term abstention, dose, and gender.Psychopharmacology.200417337638214726997
   PubMed Web of Science ®Google Scholar
• RoiserJP.CookLJ.CooperJD.et al.Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users.Am J Psychiatry.200516260961215741482
   PubMed Web of Science ®Google Scholar
• HoYJ.PawlakCR.GuoL.et al.Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat.Behav Brain Res.200414913514415129777
   PubMed Web of Science ®Google Scholar
• MenesesA.5-HT system and cognition.Neurosci Biobehav Rev.1999231111112510643820
   PubMed Web of Science ®Google Scholar
• BuhotMC.MartinS.SeguL.Role of serotonin in memory impairment.Ann Med.20003221022110821328
   PubMed Web of Science ®Google Scholar
• KachelsteinAD.De LaGR.MahoneyJJ.IIIet al.MDMA use and neurocognition: a meta-analytic review.Psychopharmacology.200718953153717082969
   PubMed Web of Science ®Google Scholar
• BediG.RedmanJ.Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.Psychol Med.2008381319133018226286
   PubMed Web of Science ®Google Scholar
• Gouzoulis-MayfrankE.DaumannJ.TuchtenhagenF.et al.Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).J Neurol Neurosurg Psychiatry.20006871972510811694
   PubMed Web of Science ®Google Scholar
• MorganMJ.ImpallomeniLC.PironaA.et al.Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to polydrug and drug-naive controls.Neuropsychopharmacology.2006311562157316292322
   PubMed Web of Science ®Google Scholar
• QuednowBB.KuhnKU.HoppeC.et al.Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (“Ecstasy”).Psychopharmacology.200718951753016425060
   PubMed Web of Science ®Google Scholar
• FoxHC.McLeanA.TurnerJJ.et al.Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (“ecstasy”) polydrug users.Psychopharmacology.200216220321412110998
   PubMed Web of Science ®Google Scholar
• Gouzoulis-MayfrankE.ThimmB.RezkM.et al.Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.Prog Neuropsychopharmacol Biol Psychiatry.20032781982712921915
   PubMed Web of Science ®Google Scholar
• CurranHV.VerheydenSL.Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.Psychopharmacology.20031699110312759801
   PubMed Web of Science ®Google Scholar
• ZakzanisKK.YoungDA.Memory impairment in abstinent MDMA (“Ecstasy”) users: a longitudinal investigation.Neurology.20015696696911294938
   PubMed Web of Science ®Google Scholar
• ZakzanisKK.CampbellZ.Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up.Neurology.20066674074116534114
   PubMed Web of Science ®Google Scholar
• Gouzoulis-MayfrankE.FischermannT.RezkM.et al.Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.Drug Alcohol Depend.20057831732315893163
   PubMed Web of Science ®Google Scholar
• SchiltT.de WinMM.KoeterM.et al.Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.Arch Gen Psychiatry.20076472873617548754
   PubMed Web of Science ®Google Scholar
• McCannUD.WongDF.YokoiF.et al.Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [1 IQWIN-35,428.J Neurosci.199818841784229763484
   PubMed Web of Science ®Google Scholar
• ErnstT.ChangL.Leonido-YeeM.et al.Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study.Neurology.2000541344134910746608
   PubMed Web of Science ®Google Scholar
• VolkowND.ChangL.WangGJ.et al.Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.J Neurosci.2001219414941811717374
   PubMed Web of Science ®Google Scholar
• VolkowND.ChangL.WangGJ.et al.Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.Am J Psychiatry.20011582015202111729018
   PubMed Web of Science ®Google Scholar
• RenemanL.BooijJ.LavalayeJ.et al.Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123l]beta-CIT SPECT study-preliminary report.Psychopharmacology.200215933534011862367
   PubMed Web of Science ®Google Scholar
• WangGJ.VolkowND.ChangL.et al.Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence.Am J Psychiatry.200416124224814754772
   PubMed Web of Science ®Google Scholar
• NordahlTE.SaloR.NatsuakiY.et al.Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.Arch Gen Psychiatry.20056244445215809412
   PubMed Web of Science ®Google Scholar
• SaloR.NordahlTE.NatsuakiY.et al.Attentional control and brain metabolite levels in methamphetamine abusers.Biol Psychiatry.2007611272128017097074
   PubMed Web of Science ®Google Scholar
• ThompsonPM.HayashiKM.SimonSL.et al.Structural abnormalities in the brains of human subjects who use methamphetamine.J Neurosci.2004246028603615229250
   PubMed Web of Science ®Google Scholar
• ChangL.CloakC.PattersonK.et al.Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response.Biol Psychiatry.20055796797415860336
   PubMed Web of Science ®Google Scholar
• ChangL.AlicataD.ErnstT.et al.Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.Addiction.2007102(suppl 1)163217493050
   PubMed Web of Science ®Google Scholar
• CaligiuriMP.BuitenhuysC.Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?.Neuropsychopharmacology.2005302125213416123755
   PubMed Web of Science ®Google Scholar
• OrnsteinTJ.IddonJL.BaldacchinoAM.et al.Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers.Neuropsychopharmacology.20002311312610882838
   PubMed Web of Science ®Google Scholar
• SimonSL.DomierC.CarnellJ.et al.Cognitive impairment in individuals currently using methamphetamine.Am J Addict.2000922223111000918
   PubMed Web of Science ®Google Scholar
• SimonSL.DomierCP.SimT.et al.Cognitive performance of current methamphetamine and cocaine abusers.J Addict Dis.200221617411831501
   PubMed Web of Science ®Google Scholar
• SaloR.NordahlTE.PossinK.et al.Preliminary evidence of reduced cognitive inhibition in methatnphetamine-dependent individuals.Psychiatry Res.2002111657412140121
   PubMed Web of Science ®Google Scholar
• Lawton-CraddockA.NixonSJ.TivisR.Cognitive efficiency in stimulant abusers with and without alcohol dependence.Alcohol Clin Exp Res.20032745746412658111
   PubMed Web of Science ®Google Scholar
• WoodsSP.RippethJD.ConoverE.et al.Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence.Neuropsychology.200519354315656761
   PubMed Web of Science ®Google Scholar
• ScottJC.WoodsSP.MattGE.et al.Neurocognitive effects of methamphetamine: a critical review and meta-analysis.Neuropsychol Rev.20071727529717694436
   PubMed Web of Science ®Google Scholar
• SpattJ.GlawarB.MamoliB.A pure amnestic syndrome after MDMA (“ecstasy”) ingestion.J Neurol Neurosurg Psychiatry.1997624184199120467
   PubMed Web of Science ®Google Scholar
• SoarK.ParrottAC.FoxHC.Persistent neuropsychological problems after 7 years of abstinence from recreational Ecstasy (MDMA): a case study.Psychol Rep.20049519219615460375
   PubMed Web of Science ®Google Scholar